Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2025-12-30 @ 1:48 AM
Study NCT ID:
NCT04338061
Status:
TERMINATED
Last Update Posted:
2025-03-21
First Post:
2020-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)
Sponsor:
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-19
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-06
First Submit QC Date:
None
Study First Post Date:
2020-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-01
Results First Submit QC Date:
None
Results First Post Date:
2025-01-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-13
Last Update Post Date:
2025-03-21
Last Update Post Date Type:
ACTUAL